1. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. (29th September 2016) Authors: Dieter, S. M.; Heining, C.; Agaimy, A.; Huebschmann, D.; Bonekamp, D.; Hutter, B.; Ehrenberg, K. R.; Fröhlich, M.; Schlesner, M.; Scholl, C.; Schlemmer, H.-P.; Wolf, S.; Mavratzas, A.; Jung, C. S.; Gröschel, S.; von Kalle, C.; Eils, R.; Brors, B.; Penzel, R.; Kriegsmann, M. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MUTATIONAL SIGNATURES IN GERMINAL CENTER DERIVED B‐CELL LYMPHOMAS FROM ADULT PATIENTS ANALYZED IN THE ICGC MMML‐SEQ CONSORTIUM. (June 2017) Authors: Huebschmann, D.; Kleinheinz, K.; Wagener, R.; Kretzmer, H.; Toprak, U.H.; Bernhart, S.H.; Lopez Gonzales, C.; Kreuz, M.; Eils, R.; Hansmann, M.; Hoffmann, S.; Hummel, M.; Klapper, W.; Lawerenz, C.; Loeffler, M.; Möller, P.; Richter, J.; Rosenstiel, P.; Rosenwald, A.; Stilgenbauer, S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗